A cost-effective algorithm for the diagnosis of Hepatitis C virus infection and prediction of HCV viremia in Cameroon

Journal of Virological Methods

Volumn 133, Issue 2, 2006, Pages 223-226

  Njouom, Richard ^a   Tejiokem, Mathurin Cyrille ^a   Zanga, Marie Claire Endegue ^a   Pouillot, Régis ^a   Ayouba, Ahidjo ^a   Pasquier, Christophe ^b   Nerrienet, Eric ^a  

^a CENTRE PASTEUR DU CAMEROUN   (Cameroon)

^b CHU PURPAN   (France)

Author keywords

Cameroon; Diagnostic; Hepatitis C virus; Rapid test; Viremia

Indexed keywords

HEPATITIS C ANTIBODY; RNA;

ACCURACY; ALGORITHM; ARTICLE; CAMEROON; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIREMIA;

ALGORITHMS; CAMEROON; COSTS AND COST ANALYSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EVALUATION STUDIES; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; PREDICTIVE VALUE OF TESTS; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; VIREMIA;

HEPATITIS C VIRUS;

EID: 33645282775     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2005.11.001     Document Type: Article

References (23)

1. V. Bossi, and C. Galli Quantitative signal of anti-HCV by an automated assay predicts viremia in a population at high prevalence of hepatitis C virus infection J. Clin. Virol. 30 2004 45 49
2. N. Boyer, and P. Marcellin Pathogenesis, diagnosis and management of hepatitis C J. Hepatol. 32 2000 98 112
3. C. Colin, D. Lanoir, S. Touzet, L. Meyaud-Kraemer, F. Bailly, and C. Trepo Sensitivity and specificity of third-generation hepatitis C virus antibody detection assays: an analysis of the literature J. Viral. Hepat. 8 2001 87 95
4. E. Delaporte, A. Froment, M. Dazza, D. Henzel, and B. Larouze Hepatitis C in remote populations of southern Cameroon Ann. Trop. Med. Parasitol. 88 1994 97 98
5. D.R. Dufour, M. Talastas, M.D.A. Fernandez, B. Harris, D.B. Strader, and L.B. Seeff Low-positive anti-hepatitis C virus enzyme immunoassay results: an important predictor of low likelihood of hepatitis C infection Clin. Chem. 49 2003 479 486
6. D.R. Dufour, J.A. Lott, F.S. Nolte, D.R. Gretch, R.S. Koff, and L.B. Seeff Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring Clin. Chem. 46 2000 2050 2068
7. S. Erensoy Diagnosis of hepatitis C virus (HCV) infection and laboratory monitoring of its therapy J. Clin. Virol. 21 2001 271 281
8. M. Kowo, P. Goubau, E. Ndam, O. Njoya, S. Sasaki, V. Seghers, and H. Kesteloot Prevalence of hepatitis C virus and other blood-borne viruses in Pygmies and neighbouring Bantus in southern Cameroon Trans. Roy. Soc. Trop. Med. Hyg. 89 1995 484 486
9. M. Krajden, R. Ziermann, A. Khan, A. Mak, K. Leung, D. Hendricks, and L. Comanor Qualitative detection of hepatitis C virus RNA: comparison of analytical sensitivity, clinical performance, and workflow of the Cobas Amplicor HCV Test Version 2.0 and the HCV RNA transcription-mediated amplification qualitative assay J. Clin. Microbiol. 40 2002 2903 2907
10. F.J. Louis, B. Maubert, J.Y. Le Hesran, J. Kemmegne, and E. Delaporte High prevalence of anti-hepatitis C virus antibodies in a Cameroon rural forest area Trans. Roy. Soc. Trop. Med. Hyg. 88 1994 53 54
11. V. Madhava, C. Burgess, and E. Drucker Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa Lancet Infect. Dis. 2 2002 293 302
12. D. Mbanya, F. Binam, and L. Kaptue Transfusion outcome in a resource-limited setting of Cameroon: a five-year evaluation Int. J. Infect. Dis. 5 2001 70 73
13. F. Morisco, G. Del Vecchio Blanc, C. Tuccillo, C. Galli, S. Cirino, and N. Caporaso Long-term observation of HCV-positive patients with normal ALT values: persistence of a clinically healthy state Res. Virol. 149 1998 277 282
14. J. Ndjomou, B. Kupfer, B. Kochan, L. Zekeng, L. Kaptue, and B. Matz Hepatitis C virus infection and genotypes among human immunodeficiency virus high-risk groups in Cameroon J. Med. Virol. 66 2002 179 186
15. E. Nerrienet, R. Pouillot, G. Lachenal, R. Njouom, J. Mfoupouendoun, C. Bilong, C. Pasquier, and A. Ayouba Hepatitis C virus infection in Cameroon: a cohort-effect J. Med. Virol. 76 2005 208 214
16. R. Njouom, C. Pasquier, A. Ayouba, A. Gessain, A. Froment, J. Mfoupouendoun, R. Pouillot, M. Dubois, K. Sandres-Saune, J. Thonnon, J. Izopet, and E. Nerrienet High rate of hepatitis C virus infection and predominance of genotype 4 among elderly inhabitants of a remote village of the rain forest of South Cameroon J. Med. Virol. 71 2003 219 225
17. R. Njouom, C. Pasquier, A. Ayouba, K. Sandres-Saune, J. Mfoupouendoun, M. Mony Lobe, G. Tene, J. Thonnon, J. Izopet, and E. Nerrienet Hepatitis C virus infection among pregnant women in Yaounde, Cameroon: prevalence, viremia, and genotypes J. Med. Virol. 69 2003 384 390
18. J. Pawlotsky Use and interpretation of hepatitis C virus diagnostic assays Clin. Liver Dis. 7 2003 127 137
19. J. Pawlotsky, I. Lonjon, C. Hezode, B. Raynard, F. Darthuy, J. Remire, C. Soussy, and D. Dhumeaux What strategy should be used for diagnosis of hepatitis C virus infection in clinical laboratories? Hepatology 27 1998 1700 1702
20. C. Payan, A. Raimbert, I. Fouchard-Hubert, S. Kouyoumdjian, and F. Lunel-Fabiani Quantitative antibody analysis: use for the diagnosis of hepatitis C virus chronic infection Ann. Biol. Clin. 61 2003 311 317
21. S.S. Richter Laboratory assays for diagnosis and management of hepatitis C virus infection J. Clin. Microbiol. 40 2002 4407 4412
22. F. Rouet, M. Chaix, A. Inwoley, P. Msellati, I. Viho, P. Combe, V. Leroy, F. Dabis, and C. Rouzioux HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Cote d'Ivoire: the ANRS 1236 study J. Med. Virol. 74 2004 34 40
23. World Health Organization Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium J. Viral. Hepat. 6 1999 35 47